Researchers at Heidelberg University Hospital have developed a PBMC-based proof-of-principle framework for fit-for-purpose ...
Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The Flow Cytometry Market research report provides a comprehensive assessment of the technologies, clinical applications ...
This eBook highlights the latest advancements in flow cytometry and imaging technologies, featuring a curated collection of posters presented at the ELRIG Drug Discovery conference. This resource is ...
A cytogenetic study of the Brazilian fire ant Solenopsis saevissima reveals naturally occurring polyploid cells with ...
ATF3-dependent IL-9 production by GITR-stimulated ILC2s promotes eosinophil accumulation and cytotoxic tumor control.
Overlapping morphologic and immunophenotypic features between MCL and plasma cell neoplasms can complicate diagnosis.
Anti-CD36 alloimmunization may contribute to severe platelet transfusion refractoriness despite negative human leukocyte ...
InvestorsHub on MSN
BioAffinity Technologies receives Japanese patent allowance for CyPath Lung AI diagnostic test
The Japanese Patent Office has signalled its intention to grant patent protection for bioAffinity Technologies’ noninvasive lung cancer detection technology, expanding the company’s intellectual ...
Researchers engineered hybrid strontium sulfite nanoparticle-modified lipid nanoparticles to deliver p53 mRNA, producing ...
Detailed price information for Bioaffinity Technologies Inc (BIAF-Q) from The Globe and Mail including charting and trades.
Detailed price information for Bioaffinity Technologies Inc (BIAF-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results